283
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment

, , , , , , , , , , , , , & show all
Pages 979-983 | Received 06 Nov 2020, Accepted 08 Jul 2020, Published online: 29 Nov 2020
 

Disclosure statement

Louise Roulin received lecture fees from Janssen. Alizée Maarek received lecture fees from Takeda and Sandoz. Corinne Haioun received consulting or lecture fees from Roche, Celgene, Janssen, Gilead, Takeda, Novartis, Amgen as well as travel accommodations from Roche, Celgene, Amgen. Karim Belhadj received consulting or lecture fees from Takeda, Amgen, Celgene, Janssen. The remaining authors declare no competing financial interests.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.